315 related articles for article (PubMed ID: 28423657)
1. Identification and characterization of RASSF1C piRNA target genes in lung cancer cells.
Reeves ME; Firek M; Jliedi A; Amaar YG
Oncotarget; 2017 May; 8(21):34268-34282. PubMed ID: 28423657
[TBL] [Abstract][Full Text] [Related]
2. RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1.
Reeves ME; Baldwin ML; Aragon R; Baldwin S; Chen ST; Li X; Mohan S; Amaar YG
BMC Res Notes; 2012 May; 5():239. PubMed ID: 22591718
[TBL] [Abstract][Full Text] [Related]
3. RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells.
Amaar YG; Reeves ME
Oncotarget; 2019 Jan; 10(2):123-132. PubMed ID: 30719208
[TBL] [Abstract][Full Text] [Related]
4. The impact of the RASSF1C and PIWIL1 on DNA methylation: the identification of GMIP as a tumor suppressor.
Amaar YG; Reeves ME
Oncotarget; 2020 Nov; 11(45):4082-4092. PubMed ID: 33227088
[TBL] [Abstract][Full Text] [Related]
5. The Role of RASSF1C in the Tumor Microenvironment.
Amaar YG; Reeves ME
Curr Issues Mol Biol; 2023 Jan; 45(2):1113-1126. PubMed ID: 36826019
[TBL] [Abstract][Full Text] [Related]
6. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer.
Weng W; Liu N; Toiyama Y; Kusunoki M; Nagasaka T; Fujiwara T; Wei Q; Qin H; Lin H; Ma Y; Goel A
Mol Cancer; 2018 Jan; 17(1):16. PubMed ID: 29382334
[TBL] [Abstract][Full Text] [Related]
7. PIWI-interacting RNAs are aberrantly expressed and may serve as novel biomarkers for diagnosis of lung adenocarcinoma.
Li J; Wang N; Zhang F; Jin S; Dong Y; Dong X; Chen Y; Kong X; Tong Y; Mi Q; Zhao Y; Zhang Y
Thorac Cancer; 2021 Sep; 12(18):2468-2477. PubMed ID: 34346164
[TBL] [Abstract][Full Text] [Related]
8. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
9. PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5.
Xie J; Xing S; Shen BY; Chen HT; Sun B; Wang ZT; Wang JW; Lu XX
Hum Cell; 2021 Mar; 34(2):550-563. PubMed ID: 33389678
[TBL] [Abstract][Full Text] [Related]
10. Multiplex bioimaging of piRNA molecular pathway-regulated theragnostic effects in a single breast cancer cell using a piRNA molecular beacon.
Lee YJ; Moon SU; Park MG; Jung WY; Park YK; Song SK; Ryu JG; Lee YS; Heo HJ; Gu HN; Cho SJ; Ali BA; Al-Khedhairy AA; Lee I; Kim S
Biomaterials; 2016 Sep; 101():143-55. PubMed ID: 27289065
[TBL] [Abstract][Full Text] [Related]
11. Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels.
Reeves ME; Firek M; Chen ST; Amaar YG
PLoS One; 2014; 9(7):e101679. PubMed ID: 25007054
[TBL] [Abstract][Full Text] [Related]
12. Serum PIWI-Interacting RNAs piR-020619 and piR-020450 Are Promising Novel Biomarkers for Early Detection of Colorectal Cancer.
Wang Z; Yang H; Ma D; Mu Y; Tan X; Hao Q; Feng L; Liang J; Xin W; Chen Y; Wu Y; Jia Y; Zhao H
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):990-998. PubMed ID: 32066615
[TBL] [Abstract][Full Text] [Related]
13. piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signaling.
Peng L; Song L; Liu C; Lv X; Li X; Jie J; Zhao D; Li D
Tumour Biol; 2016 Feb; 37(2):2749-56. PubMed ID: 26408181
[TBL] [Abstract][Full Text] [Related]
14. PIWI-Interacting RNAs in Gliomagenesis: Evidence from Post-GWAS and Functional Analyses.
Jacobs DI; Qin Q; Lerro MC; Fu A; Dubrow R; Claus EB; DeWan AT; Wang G; Lin H; Zhu Y
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1073-80. PubMed ID: 27197292
[TBL] [Abstract][Full Text] [Related]
15. Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis.
Reeves ME; Baldwin SW; Baldwin ML; Chen ST; Moretz JM; Aragon RJ; Li X; Strong DD; Mohan S; Amaar YG
BMC Cancer; 2010 Oct; 10():562. PubMed ID: 20955597
[TBL] [Abstract][Full Text] [Related]
16. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells.
Cheng J; Guo JM; Xiao BX; Miao Y; Jiang Z; Zhou H; Li QN
Clin Chim Acta; 2011 Aug; 412(17-18):1621-5. PubMed ID: 21616063
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer.
Huang G; Hu H; Xue X; Shen S; Gao E; Guo G; Shen X; Zhang X
Clin Transl Oncol; 2013 Jul; 15(7):563-8. PubMed ID: 23229900
[TBL] [Abstract][Full Text] [Related]
18. Testicular piRNA profile comparison between successful and unsuccessful micro-TESE retrieval in NOA patients.
Cao C; Wen Y; Wang X; Fang N; Yuan S; Huang X
J Assist Reprod Genet; 2018 May; 35(5):801-808. PubMed ID: 29460056
[TBL] [Abstract][Full Text] [Related]
19. piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian Cancer.
Yan Y; Tian D; Zhao B; Li Z; Huang Z; Li K; Chen X; Zhou L; Feng Y; Yang Z
Technol Cancer Res Treat; 2024; 23():15330338241249692. PubMed ID: 38706262
[TBL] [Abstract][Full Text] [Related]
20. PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.
Fu A; Jacobs DI; Hoffman AE; Zheng T; Zhu Y
Carcinogenesis; 2015 Oct; 36(10):1094-102. PubMed ID: 26210741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
